APM Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Valuation Metrics

The current forward P/E ratio for Aptorum Group Ltd (APM.O) is 0.02, compared to its 5-year average forward P/E of -1.29. For a more detailed relative valuation and DCF analysis to assess Aptorum Group Ltd 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-1.29

Current PE

0.02

Overvalued PE

0.25

Undervalued PE

-2.84

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-3.66

Current EV/EBITDA

-0.00

Overvalued EV/EBITDA

6.76

Undervalued EV/EBITDA

-14.09

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

17.46

Current PS

0.04

Overvalued PS

45.72

Undervalued PS

-10.79

Financials

Annual

Quarterly

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

APM News & Events

Events Timeline

No data

News

8.5

2025-10-09Newsfilter

Aptorum Group to Enhance Board and Management Team with Experienced Executives Amid DiamiR Biosciences Merger Plans

4.5

2025-08-22Benzinga

Dow Rises More Than 300 Points; BJ's Wholesale Stock Declines Following Q2 Earnings Report

9.5

2025-08-22Benzinga

EpicQuest Education Shares Surge Over 81%; Check Out 20 Stocks Making Moves in Premarket Trading

People Also Watch

Frequently Asked Questions

What is Aptorum Group Ltd (APM) stock price today?

The current price of APM is 1.05 USD — it has decreased -2.78 % in the last trading day.

What is Aptorum Group Ltd (APM)'s business?

Aptorum Group Limited is a United Kingdom-based clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. Its lead projects are ALS-4, SACT-1 and PathsDx Test. ALS-4 is a small drug molecule which appears to target the products produced by bacterial genes that facilitate the successful colonization and survival of the bacterium in the body or that cause damage to the body's systems. SACT-1 is the first repurposed drug candidate to be developed under the Smart-ACT drug discovery platform. The Company's pipeline is also enriched through the co-development of PathsDx Test, a molecular-based rapid pathogen identification and detection diagnostics technology, with Accelerate Technologies Pte Ltd, the commercialization arm of the Singapore's Agency for Science, Technology and Research.

What is the price predicton of APM Stock?

Wall Street analysts forecast APM stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for APM is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Aptorum Group Ltd (APM)'s revenue for the last quarter?

Aptorum Group Ltd revenue for the last quarter amounts to NaN USD, decreased % YoY.

What is Aptorum Group Ltd (APM)'s earnings per share (EPS) for the last quarter?

Aptorum Group Ltd. EPS for the last quarter amounts to USD, decreased % YoY.

What changes have occurred in the market's expectations for Aptorum Group Ltd (APM)'s fundamentals?

The market is revising No Change the revenue expectations for APM for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -55.70%.

How many employees does Aptorum Group Ltd (APM). have?

Aptorum Group Ltd (APM) has 1 emplpoyees as of January 10 2026.

What is Aptorum Group Ltd (APM) market cap?

Today APM has the market capitalization of 8.55M USD.